NME1
NME1 (NME/NM23 nucleoside diphosphate kinase 1, also known as NM23, NM23-H1 and NDPKA) is a nucleoside diphosphate kinase that maintains nucleoside triphosphate homeostasis. It was first identified through reduced transcript levels in highly metastatic cells. Browse Assay Genie's current range of NME1 research reagents below, or read on for the biology behind the target.
NME1 catalyses the transfer of a gamma-phosphoryl group from a nucleoside triphosphate, mainly ATP, to a nucleoside diphosphate. The reaction proceeds by a ping-pong mechanism through a phosphohistidine intermediate and contributes to nucleoside triphosphate homeostasis. The enzyme also phosphorylates geranyl pyrophosphate and farnesyl pyrophosphate, linking it to isoprenoid metabolism, and acts as a non-specific serine/threonine kinase and histidine protein kinase, passing phosphoryl groups from its active site to target proteins.
Beyond its kinase activities, NME1 may act as a Mg(2+)-dependent single-stranded DNA endonuclease within the SET complex. There it is proposed to cooperate with the 3'-5' exonuclease TREX1 to mediate apoptotic DNA fragmentation in cytotoxic T lymphocytes: NME1 nicks one strand and TREX1 removes nucleotides from the free 3' end. It has also been shown to cleave double-stranded DNA within the 5'-SHS silencer and NHE basal promoter element of the PDGFA gene, potentially repressing transcription, and may work as a 3'-5' DNA exonuclease. Together with NME2, it may control acetyl-CoA usage between histone acetylation and fatty acid synthesis. The protein is involved in the regulation of tumour metastasis and cellular differentiation, and is required for cell motility.
The NME1 gene was identified because of its reduced mRNA levels in highly metastatic cells, which explains the former name non-metastatic cells 1. Nucleoside diphosphate kinase exists as a hexamer of A subunits, encoded by NME1, and B subunits, encoded by NME2. The NME1 protein belongs to the NDK family. Mutations in the gene have been found in aggressive neuroblastomas. Two transcript variants encode different isoforms, and co-transcription with the neighbouring downstream gene NME2 produces NME1-NME2 read-through transcripts that encode a fusion protein.
NME1 was identified through reduced expression in highly metastatic cells and is involved in regulating tumour metastasis and cell motility.
The enzyme transfers phosphate from ATP to nucleoside diphosphates, contributing to nucleoside triphosphate homeostasis and isoprenoid metabolism.
As part of the SET complex, NME1 may cooperate with TREX1 in apoptotic DNA fragmentation in cytotoxic T lymphocytes.
Mutations in NME1 have been identified in aggressive neuroblastomas, making it a subject in studies of this tumour type.
NME1 is a nucleoside diphosphate kinase that transfers a gamma-phosphoryl group from a nucleoside triphosphate, mainly ATP, to a nucleoside diphosphate via a phosphohistidine intermediate. It also acts as a protein kinase, may have DNA nuclease activity, and is involved in metastasis regulation, differentiation and cell motility.
NME1 is also called NM23, NM23-H1, NDPKA and nucleoside diphosphate kinase A, and was previously named non-metastatic cells 1. Two transcript variants encode different isoforms. Read-through transcription with the neighbouring NME2 gene also produces an NME1-NME2 fusion protein.
NME1 has orthologues named Nme1 in both mouse and rat; check the datasheet of any product for its validated reactivity. Mutations in the human gene have been identified in aggressive neuroblastomas, and reduced expression is associated with highly metastatic cells.
NME2, the B isoform partner that forms the nucleoside diphosphate kinase hexamer with NME1.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P15531; product specifications from Assay Genie datasheets.